Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation

By M. Matsuoka, K. Jeang. Nature Reviews. Cancer, 2007

854 citations recorded by the source corpus.

Subfields: Agronomy and Crop Science, Ecology, Evolution, Behavior and Systematics, Immunology

View Paper: https://www.semanticscholar.org/paper/b84e06c5b25a9fd651cf238536b89555ab18d8b6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. H. Nishikawa
2. Shimon Sakaguchi
3. Alexander Y. Rudensky

Citations in the corpus

• HUMAN VIRAL ONCOGENESIS: A CANCER HALLMARKS ANALYSIS (2014, background): “Although many HTLV-1 genomes are deleted in their 5’ end, all of them are intact in the 3’ LTR from where they are able to stably transcribe HBZ mRNA throughout the process of infection and transformation (Matsuoka and Jeang, 2007; Satou et al., 2006).”
• Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans (2013, background): “These results collectively indicate that anti-CCR4 mAb therapy for ATL is able to selectively deplete eTreg cells as well as ATL cells in vivo, and induce/augment tumor antigenspecific T-cell responses, although it is possible that anti-CCR4 mAb-induced reduction of FOXP3 ATL cells, which reportedly”